Key signalling nodes in mammary gland development and cancer: Myc

Breast Cancer Research

Volumn 11, Issue 5, 2009, Pages

  Hynes, Nancy E ^a   Stoelzle, Tina ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; MYC PROTEIN; NOTCH RECEPTOR; WNT PROTEIN;

APOPTOSIS; BREAST CANCER; BREAST DEVELOPMENT; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; ENZYME INHIBITION; HUMAN; INVOLUTION; LACTATION; NONHUMAN; PREDICTION; PREGNANCY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; PUBERTY; REVIEW; ANIMAL; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; GROWTH, DEVELOPMENT AND AGING; MAMMARY GLAND; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; UDDER;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION;

EID: 77449112686     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2406     Document Type: Review

References (62)

1. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008, 22:2755-2766. 10.1101/gad.1712408, 2751281, 18923074.
2. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008, 8:976-990. 10.1038/nrc2231, 19029958.
3. Wierstra I, Alves J. The c-myc promoter: still MysterY and challenge. Adv Cancer Res 2008, 99:113-333. full_text, 18037408.
4. Hennighausen L, Robinson GW. Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005, 6:715-725. 10.1038/nrm1714, 16231422.
5. Vervoorts J, Luscher-Firzlaff J, Luscher B. The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 2006, 281:34725-34729. 10.1074/jbc.R600017200, 16987807.
6. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699. 10.1146/annurev.cellbio.16.1.653, 11031250.
7. Myc Cancer Gene. , http://www.myc-cancer-gene.org/index.asp
8. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 2003, 4:R69. 10.1186/gb-2003-4-10-r69, 328458, 14519204.
9. Cole MD, Cowling VH. Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol 2008, 9:810-815. 10.1038/nrm2467, 18698328.
10. Robinson GW. Cooperation of signalling pathways in embryonic mammary gland development. Nat Rev Genet 2007, 8:963-972. 10.1038/nrg2227, 18007652.
11. Howard BA. The role of NRG3 in mammary development. J Mammary Gland Biol Neoplasia 2008, 13:195-203. 10.1007/s10911-008-9082-8, 18418701.
12. Visvader JE, Lindeman GJ. Mammary stem cells and mam-mopoiesis. Cancer Res 2006, 66:9798-9801. 10.1158/0008-5472.CAN-06-2254, 17047038.
13. Tanos T, Brisken C. What signals operate in the mammary niche?. Breast Dis 2008, 29:69-82.
14. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, Trumpp A. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004, 18:2747-2763. 10.1101/gad.313104, 528895, 15545632.
15. Teuliere J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 2005, 132:267-277. 10.1242/dev.01583, 15590737.
16. Williams C, Helguero L, Edvardsson K, Haldosen LA, Gustafsson JA. Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression. Breast Cancer Res 2009, 11:R26. 10.1186/bcr2256, 2716494, 19426500.
17. Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002, 7:17-38. 10.1023/A:1015766322258, 12160083.
18. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006, 38:1289-1297. 10.1038/ng1901, 17013392.
19. Moore MR, Zhou JL, Blankenship KA, Strobl JS, Edwards DP, Gentry RN. A sequence in the 5' flanking region confers prog-estin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol 1997, 62:243-252. 10.1016/S0960-0760(97)00036-8, 9408078.
20. Master SR, Hartman JL, D'Cruz CM, Moody SE, Keiper EA, Ha SI, Cox JD, Belka GK, Chodosh LA. Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogenesis. Mol Endocrinol 2002, 16:1185-1203. 10.1210/me.16.6.1185, 12040007.
21. Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol 2008, 630:189-205.
22. Sutherland RL, Prall OW, Watts CK, Musgrove EA. Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia 1998, 3:63-72. 10.1023/A:1018774302092, 10819505.
23. Ciarloni L, Mallepell S, Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci USA 2007, 104:5455-5460. 10.1073/pnas.0611647104, 1838509, 17369357.
24. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA. Essential function of Wnt-4 in mammary gland development downstream of prog-esterone signaling. Genes Dev 2000, 14:650-654. 316462, 10733525.
25. Rosen JM. Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. Breast Dis 2003, 18:3-9.
26. D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 2001, 7:235-239. 10.1038/84691, 11175856.
27. Blakely CM, Sintasath L, D'Cruz CM, Hahn KT, Dugan KD, Belka GK, Chodosh LA. Developmental stage determines the effects of MYC in the mammary epithelium. Development 2005, 132:1147-1160. 10.1242/dev.01655, 15689376.
28. Sotgia F, Schubert W, Pestell RG, Lisanti MP. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling. Cancer Biol Ther 2006, 5:292-297.
29. Stoelzle T, Schwarb P, Trumpp A, Hynes NE. c-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland. BMC Biol 2009, 7:63. 10.1186/1741-7007-7-63, 2761394, 19785743.
30. Watson CJ. Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 2006, 8:203. 10.1186/bcr1401, 1557708, 16677411.
31. Sutherland KD, Vaillant F, Alexander WS, Wintermantel TM, Forrest NC, Holroyd SL, McManus EJ, Schutz G, Watson CJ, Chodosh LA, Lindeman GJ, Visvader JE. c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO J 2006, 25:5805-5815. 10.1038/sj.emboj.7601455, 1698901, 17139252.
32. Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J, Callahan R. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 1986, 83:4834-4838. 10.1073/pnas.83.13.4834, 323837, 3014513.
33. Deming SL, Nass SJ, Dickson RB, Trock BJ. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 2000, 83:1688-1695. 10.1054/bjoc.2000.1522, 2363455, 11104567.
34. Chen Y, Olopade OI. MYC in breast tumor progression. Expert Rev Anticancer Ther 2008, 8:1689-1698. 10.1586/14737140.8.10.1689, 18925859.
35. Nikolsky Y, Sviridov E, Yao J, Dosymbekov D, Ustyansky V, Kaz-nacheev V, Dezso Z, Mulvey L, Macconaill LE, Winckler W, Sere-bryiskaya T, Nikolskaya T, Polyak K. Genome-wide functional synergy between amplified and mutated genes in human breast cancer. Cancer Res 2008, 68:9532-9540. 10.1158/0008-5472.CAN-08-3082, 19010930.
36. Schulein C, Eilers M. An unsteady scaffold for Myc. EMBO J 2009, 28:453-454. 10.1038/emboj.2009.14, 2657581, 19262462.
37. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008, 8:83-93. 10.1038/nrc2290, 18094723.
38. Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 2007, 9:765-774. 10.1038/ncb1601, 17558397.
39. Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008, 456:971-975. 10.1038/nature07449, 19011615.
40. Cappellen D, Schlange T, Bauer M, Maurer F, Hynes NE. Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep 2007, 8:70-76. 10.1038/sj.embor.7400849, 1796762, 17159920.
41. Stewart TA, Pattengale PK, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984, 38:627-637. 10.1016/0092-8674(84)90257-5, 6488314.
42. Callahan R, Egan SE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004, 9:145-163. 10.1023/B:JOMG.0000037159.63644.81, 15300010.
43. Efstratiadis A, Szabolcs M, Klinakis A. Notch, Myc and breast cancer. Cell Cycle 2007, 6:418-429.
44. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005, 65:8530-8537. 10.1158/0008-5472.CAN-05-1069, 16166334.
45. Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G, Di Fiore PP. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004, 167:215-221. 10.1083/jcb.200406140, 2172557, 15492044.
46. Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ. Meta-analysis and gene set enrichment relative to ER status reveal elevated activity of MYC and E2F in the 'basal' breast cancer subgroup. PLoS ONE 2009, 4:e4710. 10.1371/journal.pone.0004710, 2650420, 19270750.
47. Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biol 2005, 6:R84. 10.1186/gb-2005-6-10-r84, 1257467, 16207355.
48. Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Mandinova A, Raffoul W, Fiche M, Dotto GP, Brisken C. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci USA 2006, 103:3799-3804. 10.1073/pnas.0600065103, 1450156, 16501043.
49. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 2009, 11:R32. 10.1186/bcr2317, 2716500, 19473496.
50. Cowling VH, D'Cruz CM, Chodosh LA, Cole MD. c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol 2007, 27:5135-5146. 10.1128/MCB.02282-06, 1951955, 17485441.
51. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007, 446:676-679. 10.1038/nature05674, 17377531.
52. Reed KR, Athineos D, Meniel VS, Wilkins JA, Ridgway RA, Burke ZD, Muncan V, Clarke AR, Sansom OJ. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci USA 2008, 105:18919-18923. 10.1073/pnas.0805778105, 2596219, 19033191.
53. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004, 6:497-506. 10.1016/j.ccr.2004.09.032, 15542433.
54. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transacti-vation. Breast Cancer Res 2007, 9:R63. 10.1186/bcr1769, 2242658, 17897439.
55. Lane HA, Beuvink I, Motoyama AB, Daly JM, Neve RM, Hynes NE. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overex-pression does not determine growth dependency. Mol Cell Biol 2000, 20:3210-3223. 10.1128/MCB.20.9.3210-3223.2000, 85615, 10757805.
56. Neve RM, Sutterluty H, Pullen N, Lane HA, Daly JM, Krek W, Hynes NE. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Oncogene 2000, 19:1647-1656. 10.1038/sj.onc.1203470, 10763821.
57. Arpino G, Wiechmann L, Osborne CK, Schiff R. Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev 2008, 29:217-233. 10.1210/er.2006-0045, 2528847, 18216219.
58. Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 1998, 139:4164-4174. 10.1210/en.139.10.4164, 9751496.
59. Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schutte J, Gardiner-Garden M, Ormandy CJ, McArthur G, Butt AJ, Sutherland RL. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS ONE 2008, 3:e2987. 10.1371/journal.pone.0002987, 2496892, 18714337.
60. Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS One 2008, 3:e1908. 10.1371/journal.pone.0001908, 2270912, 18382681.
61. Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006, 16:318-330. 10.1016/j.semcancer.2006.07.015, 16934487.
62. Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM. Molecular concepts analysis links tumors, pathways, mechanisms, and drugs. Neoplasia 2007, 9:443-454. 10.1593/neo.07292, 1877973, 17534450.